Advertisement
Home 2016 April

Monthly Archives: April 2016

For long-stay nursing home decedents

Hospice Care Doesn’t Up Costs for Nursing Home Decedents

0
For long-stay nursing home decedents, use of hospice doesn't increase costs in last 6 months of life
For young adults presenting to the emergency department with acute chest pain

Review Addresses Chest Pain in Young Adults Presenting to ER

0
Physicians should focus on stress reaction after ruling out cardiac risk, based on risk factors, history
Despite an increased proportion of Bordetella pertussis isolates lacking pertactin

Efficacy of DTaP, Tdap Holds Despite Pertactin Deficiency

0
Similar estimates for DTaP, Tdap VE to other settings, despite high prevalence of pertactin deficiency
Use of a clinical pathway-specific Maternal Early Warning Trigger tool can reduce maternal morbidity

Early Warning Trigger Tool Could Help Reduce Maternal Morbidity

0
Use of tool cuts severe maternal morbidity and composite morbidity; no change in ICU admissions
Coronary computed tomography angiography is associated with more appropriate use of invasive angiography and increased use of preventive therapies

CCTA Tied to More Appropriate Use of Invasive Angiography

0
Patients undergoing coronary computed tomography angiography initiate more preventive therapies
Inhibition of phosphodiesterase-4

PDE4 Inhibition Promising Tx for Metabolic Disorders

0
Derangement of PDE4-cAMP signaling is pathophysiologically relevant in metabolic disorders
New-onset atrial fibrillation after acute myocardial infarction is strongly tied to in-hospital complications and higher short-term readmission rates

New-Onset A-Fib Post Acute MI Ups Complications, Readmission

0
In-hospital complication rate higher, as is 30-day readmission rate
Iodine-125 permanent interstitial implantation is associated with long-term

Iodine-125 Interstitial Implant Feasible for Prostate Cancer

0
Findings based on 10-year follow-up of localized prostate cancer patients
Venclexta (venetoclax) has been approved by the U.S. Food and Drug Administration to treat chronic lymphocytic leukemia characterized by a specific chromosomal abnormality

FDA Approves Venclexta for CLL With 17p Deletion

0
Drug sanctioned for chronic lymphocytic leukemia in patients with a specific chromosomal abnormality
The U.S. Preventive Services Task Force recommends aspirin use for primary prevention of cardiovascular disease and colorectal cancer in certain adults aged 50 to 69 years

USPSTF: Aspirin Recommended for Some Aged 50 to 69 Years

0
Benefits for primary prevention of CVD, CRC for certain adults aged 50 to 69 years